← Leaderboards
Nancy D Leslie
Children'S Hospital Med Ctr (Cincinnati)
$133,638
Attributed
$133,638
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $39.6K · FY2005–07$50K$37.5K$25K$12.5K$0
'05
'06
'07
Funding mix
By agency
NIH$133,638 · 8
By mechanism
M01$133,638 · 8
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Med Ctr (Cincinnati)
Same institution · by research overlap
- Kenneth David Setchell$3,073,583
- Michael T Williams$3,436,985
Others in their field
Top investigators on “Source”
- Richard A Gibbs · Baylor College Of Medicine$285,393,445
- David Heimbrook · Leidos Biomedical Research, Inc.$233,184,481
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Jeffrey P Krischer · University Of South Florida$224,745,020
- Albert Lazzarini · California Institute Of Technology$202,317,285
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$155,571,437
Research focus
SourcePharmaceutical PreparationsInstitutionSafetyResearch PersonnelGlycogen Storage Disease Type IiAffectHuman SubjectPharmacokineticsResourcesUnited States National Institutes Of HealthDrug Adverse EffectDrug Screening /EvaluationGrantClinical ResearchEnzymesComputer Retrieval Of Information On Scientific Projects DatabaseFundingEffectivenessChronic Disease /DisorderHeart FailureDrug Administration Rate /DurationChondroitin Sulfate BCardiomegaly
Grant awards (10)
IDURONATE-2-SULFATASE REPLACEMENT THERAPY IN MPS II$12,814
M01 · FY2007 · RR · contact PI
RHGAA TREATMENT IN PATIENTS OVER 6 AND LESS THAN 36 MONTHS OLD$8,358
M01 · FY2007 · RR · contact PI
RHGAA TREATMENT IN PATIENTS OVER 6 AND LESS THAN 36 MONTHS OLD$18,904
M01 · FY2006 · RR · contact PI
IDURONATE-2-SULFATASE REPLACEMENT THERAPY IN MPS II$15,359
M01 · FY2006 · RR · contact PI
RHGAA TREATMENT IN PATIENTS < 6 MONTHS OLD$5,316
M01 · FY2006 · RR · contact PI
RHGAA TREATMENT IN PATIENTS OVER 6 AND LESS THAN 36 MONTHS OLD$21,207
M01 · FY2005 · RR
IDURONATE-2-SULFATASE REPLACEMENT THERAPY IN MPS II$11,526
M01 · FY2005 · RR
RHGAA TREATMENT IN PATIENTS <6 MONTHS OLD$6,916
M01 · FY2005 · RR
RhGAA Treatment in Patients Over 6 &Less than 36 Months$32,711
M01 · FY2004 · RR
Iduronate-2-Sulfatase Replacement Therapy in MPS II$527
M01 · FY2004 · RR